Stock comparison
AMGEN INC is 49.4x more valuable than Relay Therapeutics, Inc. by market capitalization ($196.28 B vs $3.98 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 49.4x more valuable than Relay Therapeutics, Inc. by market capitalization ($196.28 B vs $3.98 B).
Market value leader
AMGN
AMGEN INC is 49.4x more valuable than Relay Therapeutics, Inc. by market capitalization ($196.28 B vs $3.98 B).
Revenue leader
AMGN
RLAY: $15.36M vs AMGN: $36.75B.
Profit leader
AMGN
RLAY: -$276.48M vs AMGN: $7.71B.
Margin leader
AMGN
RLAY: -1800.6% vs AMGN: 21.0% net margin.
| Metric | RLAY | AMGN |
|---|---|---|
| Market cap | $3.98 B | $196.28 B |
| US-listed rank | #1611 | #75 |
| Revenue (latest FY) | $15.36M | $36.75B |
| Net income (latest FY) | -$276.48M | $7.71B |
| Net margin | -1800.6% | 21.0% |
| P/E (trailing FY) | - | 25.5x |
| SEC filings | 506 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 49.4x more valuable than Relay Therapeutics, Inc. by market capitalization ($196.28 B vs $3.98 B).
In their latest fiscal years, Relay Therapeutics, Inc. reported $15.36M in revenue while AMGEN INC reported $36.75B.
Full pages: Relay Therapeutics, Inc. and AMGEN INC, or browse the full rankings.